Estrogen receptor α-immunoreactive astrocytes are increased in the hippocampus in Alzheimer's disease

Experimental Neurology

Volumn 183, Issue 2, 2003, Pages 482-488

  Lu, Ya Ping ^a   Zeng, Mei ^a   Hu, Xiang You ^a   Xu, Hao ^a   Swaab, Dick F ^b   Ravid, Rivka ^b   Zhou, Jiang Ning ^a,c  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Astrocyte; Estrogen receptor; Hippocampus

Indexed keywords

ESTROGEN RECEPTOR ALPHA; GLIAL FIBRILLARY ACIDIC PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; PRIORITY JOURNAL;

EID: 0141449005     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00205-X     Document Type: Article

References (69)

1. Asthana S., Baker L.D., Craft S., Stanczyk F.Z., Veith R.C., Raskind M.A., Plymate S.R. High-dose estradiol improves cognition for women with AD results of a randomized study . Neurology. 57:2001;605-612.
2. Asthana S., Craft S., Baker L.D., Raskind M.A., Birnbaum R.S., Lofgreen C.P., Veith R.C., Plymate S.R. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease results of a placebo-controlled, double-blind, pilot study . Psychoneuroendocrinology. 24:1999;657-677.
3. Azcoitia I., Sierra A., Garcia-Segura L.M. Localization of estrogen receptor β-immunoreactivity in astrocytes of the adult rat brain. Glia. 26:1999;260-267.
4. Azcoitia I., Sierra A., Veiga S., Honda S., Harada N., Garcia-Segura L.M. Brain aromatase is neuroprotective. J. Neurobiol. 47:2001;318-329.
5. Blurton-Jones M., Tuszynski M.H. Reactive astrocytes express estrogen receptors in the injured primate brain. J. Comp. Neurol. 433:2001;115-123.
6. Brenner D.E., Kukull W.A., Stergachis A., Van Belle G., Bowen J.D., McCormick W.C., Teri L., Larson E.B. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease a population-based case-control study . Am. J. Epidemiol. 140:1994;262-267.
7. Costa M.M., Reus V.I., Wolkowitz O.M., Manfredi F., Lieberman M. Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women. Biol. Psychiatry. 46:1999;182-188.
8. Cui W., Allen N.D., Skynner M., Gusterson B., Clark A.J. Inducible ablation of astrocytes shows that these cells are required for neuronal survival in the adult brain. Glia. 34:2001;272-282.
9. Day J.R., Laping N.J., McNeill T.H., Schreiber S.S., Pasinetti G., Finch C.E. Castration enhances expression of glial fibrillary acidic protein and sulfated glycoprotein-2 in the intact and lesion-altered hippocampus of adult male rat. Mol. Endocrinol. 4:1990;1995-2002.
10. Derek T.S., Robert J.H. Localization of estrogen receptor α (ERα) in pyramidal neurons of the developing rat hippocampus. Dev. Brain Res. 128:2001;165-175.
11. Dhandapani K.M., Brann D.W. Estrogen-astrocyte interactions implications for neuroprotection . BMC Neurosci. 3:2002;6.
12. Dodel R.C., Du Y., Bales K.R., Gao F., Paul S.M. Sodium salicylate and 17 β-estradiol attenuate nuclear transcription factor NF-kB translocation in cultured rat astroglial cultures following exposure to amyloid A β (1-40) and lipopolysaccharides. J. Neurochem. 73:1999;1453-1460.
13. Donahue J.E., Stopa E.G., Chorsky R.L., King J.C., Schipper H.M., Tobet S.A., Blaustein J.D., Reichlin S. Cells containing immunoreactive estrogen receptor-α in the human basal forebrain. Rain Res. 856:2000;142-151.
14. Doraiswany P.M., Bieber F., Kaiser L., Krishnan K.R., Reuning S.J., Gulanski B. The Alzhemer's disease assessment scale patterns and predictors of baseline cognitive performance in multicenter Alzhemer's disease trials . Neurology. 48:1997;1511-1517.
15. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I., Wise P.M. Estradiol modulates bcl-2 in cerebral ischemia a potential role for estrogen receptors . J. Neurosci. 19:1999;6385-6393.
16. Duvernoy H.M. The Human Hippocampus, Functional Anatomy, Vascularization and Serian Sections with MRI. 1997;Springer, Berlin.
17. Eberling J.L. Oestrogen has neuroprotective effects and may reduce the risk of Alzheimer's disease. Expert. Opin. Biol. Ther. 2:2002;647-657.
18. Friedland R.P. Alzheimer's disease clinical features and differenrial diagnosis . Neurology. 43:1993;S45-S52.
19. Garcia-Estrada J., Del Rio J.A., Luquin S., Soriano E., Garcia-Segura L.M. Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury. Brain Res. 628:1993;271-278.
20. Garcia-Estrada J., Luquin S., Fernandez A., Garcia-Segura L.M. Dehydroepiandrosterone, pregnenolone and sex steroids down-regulate reactive astroglia in the male rat brain after a penetrating brain injury. Int. J. Dev. Neurosci. 17:1999;145-151.
21. Garcia-Ovejero D., Veiga S., Garcia-Segura L.M., Doncarlos L.L. Glial expression of estrogen and androgen receptors after rat brain injury. J. Comp. Neurol. 450:2002;256-271.
22. Garcia-Segura L.M., Azcoitia I., DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63:2001;29-60.
23. Gould E., Woolley C.S., Frankfurt M., McEwen B.S. Gonadal steroids regulate dendritic spine density in hippocampal cells in adulthood. J. Neurosci. 10:1990;1286-1291.
24. Green P.S., Simpkins J.W. Neuroprotective effects of estrogens potential mechanisms of action . Int. J. Dev. Neurosci. 18:2000;347-358.
25. Henderson V.W. Estrogen replacement therapy for the prevention and treatment of Alzhemer's disease. CCNS Drugs. 8:1997;343-351.
26. Henderson V.W., Paganini-Hill A., Emanuel C.K., Dunn M.E., Buckwalter J.G. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and non-demented control subjects. Arch. Neurol. 51:1994;896-900.
27. Hosli E., Ruhl W., Hosli L. Histochemical and electrophysiological evidence for estrogen receptors on cultured astrocytes colocalization with cholinergic receptors . Int. J. Dev. Neurosci. 18:2000;101-111.
28. NTR expression in hippocampal neurons containing hyperphosphorylated T in Alzheimer patients . Exp. Neurol. 178:2002;104-111.
29. Hyman B.T., Van Hoesen G.W., Damasio A.R. Alzheimer's disease glutamate depletion in the hippocampal perforant pathway zone . Ann. Neurol. 22:1987;37-40.
30. Hyman B.T., Van Horsen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease cell-specific pathology isolates the hippocampal formatiom . Science. 225:1984;1168-1170.
31. Ishunina T.A., Kruijver F.P.M., Balesar R., Swaab D.F. Differential expression of estrogen receptor α and β immunoreactivity in the human supraoptic nucleus in relation to sex and aging. J. Clin. Endocrinol. Metab. 85:2000;3283-3291.
32. Ishunina T.A., Swaab D.F. Increased expression of estrogen receptor α and β in the nucleus basalis of Meynert in Alzheimer's disease. Neurobiol. Aging. 22:2001;417-426.
33. Ivanova T., Mendez P., Garcia-Segura L.M., Beyer C. Rapid stimulation of the P13-kinase/Akt signalling pathway in developing midbrain neurones by oestrogen. J. Neuroendocrinol. 14:2002;73-79.
34. Katzman R., Saitoh T. Advances in Alzheimer's disease. Fed. Am. Soc. Exp. Biol. J. 5:1991;278-286.
35. Langub M.C. Jr., Watson R.E. Jr. Estrogen receptor immunoreactive glia, endothelia, and ependyma in guinea pig preoptic area and median eminence electron microscopy . Endocrinology. 130:1992;364-372.
36. Liang Z., Valla J., Sefidvash-Hockley S., Rogers J., Li R. Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients. J. Neurochem. 80:2002;807-814.
37. Liu R.Y., Zhou J.N., Hoogendijk W.J.G., Heerikhuize J.V., Kamphorst W., Unmehopa U.A., Hofman M.A., Swaab D.F. Decreased vasopressin gene expression in the biological clock of Alzheimer's disease patients with and without depression. J. Neuropathol. Exp. Neurol. 59:2000;314-322.
38. Luine V.N. Steroid hormone modulation of hippocampal dependent spatial memory. Stress. 2:1997;21-36.
39. McCarthy J.B., Barker-Gibb A.L., Alves S.E., Milner T.A. TrkA immunoreactive astrocytes in dendritic fields of the hippocampal formation across estrous. Glia. 38:2002;36-44.
40. McEwen B.S. Gonadal steroid influences on brain development and sexual differentiation. Int. Rev. Physiol. 27:1983;99-145.
41. Mckhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease . Neurology. 34:1984;939-944.
42. Milner T.A., McEwen B.S., Hayashi S., Li C.J., Reagan L.P., Alves S.E. Ultrastructural evidence that hippocampal α estrogen receptors are located at extranuclear sites. J. Comp. Neurol. 429:2001;355-371.
43. Mosselman S., Polman J., Dijkema R. ERβ identification and characterization of a novel human estrogen receptor . FEBS Lett. 392:1996;49-53.
44. Mufson E.J., Cai W.J., Jaffar S., Chen E.Y., Stebbins G., Sendera T., Kordower J.H. Estrogen receptor immunoreactivity within subregions of the rat forebrain neuronal distribution and association with perikarya containing choline acetyltransferase . Brain Res. 849:1999;253-274.
45. Mulnard R.A., Cotman C.W., Kawas C., Van Dyck C.H., Sano M., Doody R., Koss E., Pfeiffer E., Jin S., Gamst A., Grundman M., Thomas R., Thal L.J. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease a randomized controlled trial. Alzheimer's Disease Cooperative Study . JAMA. 283:2000;1007-1015.
46. Packard M.G., Teather L.A. Intra-hippocampal estradiol infusion enhances memory in ovariectomized rats. NeuroReport. 8:1997;3009-3013.
47. Polo-Kantola P., Portin R., Polo O., Helenius H., Irjala K., Erkkola R. The effect of short-term estrogen replacement therapy on cognition a randomized, double-blind, cross-over trial in postmenopausal women . Obstet. Gynecol. 91:1998;459-466.
48. Register T.C., Shively C.A., Lewis C.E. Expression of estrogen receptor α and β transcripts in female monkey hippocampus and hypothalamus. Brain Res. 788:1998;320-322.
49. Resnick S.M., Maki P.M., Golski S., Kraut M.A., Zonderman A.B. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Hormones Behav. 34:1998;171-182.
50. Rissanen A., Puolivali J., Van Groen T., Riekkinen P. In mice tonic estrogen replacement therapy improves non-spatial and spatial memory in a water maze task. NeuroReport. 10:1999;1369-1372.
51. Salehi A., Ravid R., Gonatas N.K., Swaab D.F. Decreased activity of hippocampal neurons in Alzheimer's disease is not related to the presence of neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 54:1995;704-709.
52. Savaskan E., Olivieri G., Meier F., Ravid R., Muller-Spahn F. Hippocampal estrogen β -receptor immunoreactivity is increased in Alzheimer's disease. Brain Res. 908:2001;113-119.
53. Schneider L.S., Finch C.E. Can estrogens prevent neurodegeneration? Drugs Aging. 11:1997;87-95.
54. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
55. Sherwin B.B. Estrogen effects on cognition in menopausal women. Neurology. 48:1997;S21-S26.
56. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor α and β mRNA in the rat central nervous system. J. Comp. Neurol. 388:1997;507-525.
57. Shughrue P.J., Scrimo P.J., Merchenthaler I. Estrogen binding and estrogen receptor characterization (ERα and ERβ) in the cholinergic neurons of the rat basal forebrain. Neuroscience. 96:2000;41-49.
58. Slooter A.J., Bronzova J., Witteman J., Van Broeckhoven C., Hofman A., Van Duijn C.M. Estrogen use and early onset Alzheimer's disease a population-based study . J. Neurol. Neurosurg. Psychiatry. 67:1999;779-781.
59. Stone D.J., Rozovsky I., Morgan T.E., Anderson C.P., Hajain H., Finch C.E. Astrocytes and microglia respond to estrogen with increased ApoE mRNA in vivo and in vitro. Exp. Neurol. 143:1997;313-318.
60. Stone D.J., Song Y., Anderson C.P., Krohn K.K., Finch C.E., Rozovsky I. Bidirectional transcription regulation of glial fibrillary acidic protein by estradiol in vivo and in vitro. Endocrinology. 139:1998;3202-3209.
61. Su J.D., Qiu J., Zhong Y.P., Li X.Y., Wang J.W., Chen Y.Z. Expression of estrogen receptor (ER)-α and -β immunoreactivity in hippocampal cell cultures with special attention to GABAergic neurons. J. Neurosci. Res. 65:2001;396-402.
62. Sudo S., Wen T.C., Desaki J., Matsuda S., Tanaka J., Arai T., Maeda N., Sakanaka M. β -Estradiol protects hippocampal CA1 neurons against transient forebrain ischemia in gerbil. Neurosci. Res. 29:1997;345-354.
63. Swaab D.F., Lucassen P.J., Salehi A., Scherder E.J., Van Someren E.J., Verwer R.W. Reduced neuronal activity and reactivation in Alzheimer's disease. Prog. Brain Res. 117:1998;343-377.
64. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
65. Van de Nes J.A.P., Kamphorst W., Ravid R., Swaab D.F. Comparison of β-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients amorphic plaques and cytoskeletal changes occur independently . Acta Neuropathol. (Berlin). 96:1998;129-138.
66. Waring S.C., Rocca W.A., Petersen R.C., O'Brien P.C., Tangalos E.G., Kokmen E. Postmenopausal estrogen replacement therapy and risk of AD a population-based study . Neurology. 52:1999;965-970.
67. Woolley C.S., McEwen B.S. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J. Neurosci. 12:1992;2549-2554.
68. Yaffe K., Sawaya G., Lieberburg I., Grady D. Estrogen therapy in postmenopausal women effects on cognitive function and dementia . JAMA. 279:1998;688-695.
69. Zwain I.H., Arroyo A., Amato P., Yen S.S. A role for hypothalamic astrocytes in dehydroepiandrosterone and estradiol regulation of gonadotropin-releasing hormone (GnRH) release by GnRH neurons. Neuroendocrinology. 75:2002;375-383.